DB17606InvestigationalCell transplant therapies
Rexlemestrocel-L is an investigational human bone marrow-derived allogeneic mesenchymal precursor cell (MPC) product. It is being investigated in various cardiac conditions, such as chronic heart failure and acute myocardial infarction.
- Also known as
- Allogeneic human bone marrow-derived mpc · Allogeneic mesenchymal precursor cell · Immunoselected stro-3+ allogenic mesenchymal precursor cells · Neofuse · Revascor
- Code names
- CEP-41750
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Rexlemestrocel-L, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account